Takanori Matsuo

Development and effect of alkali treatment on tensile properties of curaua fiber green composites

Alexandre Gomes, Takanori Matsuo, Koichi GODA et al. · Composites Part A Applied Science and Manufacturing · 2007 · 312 citations

Materials Science, Fiber Reinforcement, Reinforcement Material +8

Phosphodiesterase 4 inhibition reduces lung fibrosis following targeted type II alveolar epithelial cell injury

Thomas H. Sisson, Paul J. Christensen, Yo Muraki et al. · Physiological Reports · 2018 · 54 citations · Full text

Acute Lung Injury, Antifibrotic Therapy, Inflammatory Lung Disease +25

Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure

Masakuni Noda, Takanori Matsuo, Ryo Fukuda et al. · Kidney International · 1999 · 48 citations · Full text

Urology, Renal Function, Chronic Renal Failure +10

A new class of non-thiazolidinedione, non-carboxylic-acid-based highly selective peroxisome proliferator-activated receptor (PPAR) γ agonists: Design and synthesis of benzylpyrazole acylsulfonamides

Kentaro Rikimaru, Takeshi Wakabayashi, Hidenori Abe et al. · Bioorganic & Medicinal Chemistry · 2011 · 42 citations · Full text

Pharmaceutical Science, Diversity Oriented Synthesis, Biochemistry +9

Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti‐inflammatory effects in mdx mice with Duchenne muscular dystrophy

Yasunori Nio, Masayuki Tanaka, Yoshihiko Hirozane et al. · The FASEB Journal · 2017 · 28 citations

Mechanobiology, Antifibrotic Therapy, Muscle Function +15